Copyright
©The Author(s) 2024.
World J Clin Oncol. Mar 24, 2024; 15(3): 381-390
Published online Mar 24, 2024. doi: 10.5306/wjco.v15.i3.381
Published online Mar 24, 2024. doi: 10.5306/wjco.v15.i3.381
Type | Technique | Indication | Complications |
Percutaneous drainage | PTBD | Proximal malignant biliary obstructions (particularly Bismuth type III and IV peri-hilar CCA patients) | Catheter-related complications: wound care, hygiene maintenance, catheter dislodgement, and PTBD blockages |
Acute cholangitis, bleeding, and peri catheter leakage | |||
PTBS | Specific patients with malignant biliary obstruction | No catheter-related complications (due to no external drainage) | |
Cholangitis, pancreatitis, bleeding, stent dysfunction, cholecystitis, duodenal perforation, stent obstruction (due to tumor overgrowth) | |||
Endoscopic drainage | ERCP with biliary stenting | Patients with incurable conditions (e.g. Unresectable tumors, malignant hilar obstruction) | Stent occlusion or dysfunction (mainly due to tumor ingrowth) |
EUS-EBD | Cases where ERCP may be difficult due to anatomical variations, altered anatomy from prior surgeries or tumor infiltration | Minimal complications including pancreatitis and cholecystitis | |
Surgical Drainage (only considered as a final option after failure of other approaches) | Choledochojejunostomy | Distal CCA | High perioperative morbidity and mortality |
Intrahepatic bile duct bypass | Peri hilar CCA | ||
Extrahepatic bile duct bypass | Distal obstruction or Bismuth type I | ||
Left hepaticojejunostomy | Bismuth type IIIa | ||
Right hepaticojejunostomy | Bismuth type IIIb | ||
Right or left sectoral duct bypass | Bismuth type IV | High perioperative morbidity and mortality | |
Frequently ineffective due to inadequacy of a single anastomosis to drain a sufficient volume of functioning liver |
- Citation: Makki M, Bentaleb M, Abdulrahman M, Suhool AA, Al Harthi S, Ribeiro Jr MA. Current interventional options for palliative care for patients with advanced-stage cholangiocarcinoma. World J Clin Oncol 2024; 15(3): 381-390
- URL: https://www.wjgnet.com/2218-4333/full/v15/i3/381.htm
- DOI: https://dx.doi.org/10.5306/wjco.v15.i3.381